Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Cell Stem Cell. 2011 Nov 4;9(5):413-9. doi: 10.1016/j.stem.2011.09.011. Epub 2011 Oct 20.
Recent advances in somatic cell reprogramming have highlighted the plasticity of the somatic epigenome, particularly through demonstrations of direct lineage reprogramming of one somatic cell type to another by defined factors. However, it is not clear to what extent this type of reprogramming is able to generate fully functional differentiated cells. In addition, the activity of the reprogrammed cells in cell transplantation assays, such as those envisaged for cell-based therapy of Parkinson's disease (PD), remains to be determined. Here we show that ectopic expression of defined transcription factors in mouse tail tip fibroblasts is sufficient to induce Pitx3+ neurons that closely resemble midbrain dopaminergic (DA) neurons. In addition, transplantation of these induced DA (iDA) neurons alleviates symptoms in a mouse model of PD. Thus, iDA neurons generated from abundant somatic fibroblasts by direct lineage reprogramming hold promise for modeling neurodegenerative disease and for cell-based therapies of PD.
体细胞重编程的最新进展强调了体细胞表观基因组的可塑性,特别是通过明确的因子将一种体细胞类型直接重编程为另一种体细胞类型的演示。然而,目前尚不清楚这种类型的重编程在多大程度上能够产生完全功能分化的细胞。此外,在细胞移植实验中,如帕金森病 (PD) 的基于细胞治疗中设想的那样,重编程细胞的活性仍有待确定。在这里,我们表明在小鼠尾尖成纤维细胞中异位表达定义的转录因子足以诱导产生与中脑多巴胺能 (DA) 神经元非常相似的 Pitx3+神经元。此外,移植这些诱导产生的 DA (iDA) 神经元可缓解 PD 小鼠模型的症状。因此,通过直接谱系重编程从丰富的体细胞成纤维细胞中产生的 iDA 神经元有望用于模拟神经退行性疾病和 PD 的基于细胞的治疗。